Clinical Trial

Clinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary Disease

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 2, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, randomized, parallel group, sham-controlled, multicenter clinical trial. The objective is to evaluate the safety and effectiveness of pulsed electric field ablation system manufactured by Suzhou Hengruihongyuan Medical Technology Co., Ltd. for the treatment of the symptoms of chronic bronchitis in adult COPD patients with moderate to severe chronic bronchitis. A total of 210 patients will be randomized into the experimental group and the sham group (2:1).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-06.
Status change: Not Yet Recruiting → Recruiting 2025-08-25
Trial Details
NCT Number NCT07068438
Lead Sponsor Suzhou Hengruihongyuan Medical Technology Co. LTD
Conditions Chronic Bronchitis, COPD (Chronic Obstructive Pulmonary Disease)
Enrollment 210 participants
Start Date 2025-09-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-02